May 4 (Reuters) - Johnson & Johnson's consumer
health unit Kenvue Inc was set to fetch a valuation of
up to $46.7 billion on Thursday, as its shares were indicated to
open nearly 14% above their offer price on the NYSE.
Kenvue had priced its shares at $22 apiece.
(Reporting by Manya Saini and Bhanvi Satija in Bengaluru;
Editing by Shounak Dasgupta and Shinjini Ganguli)
Disclaimer: The views expressed in this article are those of the author and may not reflect those of Kitco Metals Inc. The author has made every effort to ensure accuracy of information provided; however, neither Kitco Metals Inc. nor the author can guarantee such accuracy. This article is strictly for informational purposes only. It is not a solicitation to make any exchange in commodities, securities or other financial instruments. Kitco Metals Inc. and the author of this article do not accept culpability for losses and/ or damages arising from the use of this publication.